Loading company…
Napo Pharmaceuticals develops prescription medicines for patients with gastrointestinal conditions, including treatment-related symptoms.
Napo Pharmaceuticals develops and commercializes prescription medicines, particularly for gastrointestinal distress associated with cancer treatment. Founded in 2001, the company is based in San Francisco, US. Its latest funding round was Venture Debt in January 2017, raising USD 2.00 mn from Kingdon Capital Management. Lisa Conte serves as CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in